Milne George M Jr
- SEC CIK
- 0001179552
No open-market purchases or sales filed in the past year.
Current role at each company
- AMLX Amylyx Pharmaceuticals, Inc.Directoras of Jun 8, 2026
- AUPH Aurinia Pharmaceuticals Inc.Directoras of May 23, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Milne George M Jr as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
AMLX Amylyx Pharmaceuticals, Inc.
Director3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 5, 2024 (view filing) | Sep 3 | 2 days | Milne George M JrDirector | PPurchase | +100.0K | $2.20 | +$220.0K | +13.2%858.6K after | |
| Mar 20, 2023 (view filing) | Mar 16 | 4 days | Milne George M JrDirector | SSale | −35.0K | $31.89 | −$1.12M | −3.9%862.0K after | 2 lots |
| Jan 10, 2022 (view filing) | Jan 6 | 4 days | Milne George M JrDirector | PPurchase | +26.3K | $19.00 | +$500.0K | +13.5%221.4K after |
AUPH Aurinia Pharmaceuticals Inc.
Director2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 6, 2023 (view filing) | Mar 2 | 4 days | Milne George M JrDirector | PPurchase | +20.0K | $8.91 | +$178.2K | +40.0%70.0K after | |
| Mar 8, 2022 (view filing) | Mar 4 | 4 days | Milne George M JrDirector | PPurchase | +5.00K | $10.82 | +$54.1K | +11.1%50.0K after |